Karianne G. Fleten

507 total citations
21 papers, 334 citations indexed

About

Karianne G. Fleten is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Karianne G. Fleten has authored 21 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Karianne G. Fleten's work include Intraperitoneal and Appendiceal Malignancies (9 papers), Nanoparticle-Based Drug Delivery (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Karianne G. Fleten is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (9 papers), Nanoparticle-Based Drug Delivery (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Karianne G. Fleten collaborates with scholars based in Norway, United States and France. Karianne G. Fleten's co-authors include Kjersti Flatmark, Gunhild M. Mælandsmo, Viví Ann Flørenes, Birgit Engesæter, Christin Lund‐Andersen, Lina Prasmickaite, Mads H. Haugen, Ýrr Mørch, Anne Hansen Ree and Viola Nähse and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Karianne G. Fleten

21 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karianne G. Fleten Norway 12 140 108 79 50 44 21 334
Shaomin Che China 12 155 1.1× 112 1.0× 37 0.5× 64 1.3× 57 1.3× 17 355
Caterina Malcontenti‐Wilson Australia 13 112 0.8× 107 1.0× 106 1.3× 27 0.5× 49 1.1× 21 426
Chiara Barozzi Italy 13 224 1.6× 130 1.2× 86 1.1× 22 0.4× 51 1.2× 25 534
Veronika Ecker Germany 8 180 1.3× 149 1.4× 18 0.2× 64 1.3× 62 1.4× 12 404
Tsutomu Imanishi Japan 11 198 1.4× 160 1.5× 89 1.1× 37 0.7× 57 1.3× 21 413
Pietro Parcesepe Italy 13 194 1.4× 254 2.4× 60 0.8× 24 0.5× 79 1.8× 21 489
M. McNamara United States 11 272 1.9× 152 1.4× 37 0.5× 34 0.7× 44 1.0× 28 439

Countries citing papers authored by Karianne G. Fleten

Since Specialization
Citations

This map shows the geographic impact of Karianne G. Fleten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karianne G. Fleten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karianne G. Fleten more than expected).

Fields of papers citing papers by Karianne G. Fleten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karianne G. Fleten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karianne G. Fleten. The network helps show where Karianne G. Fleten may publish in the future.

Co-authorship network of co-authors of Karianne G. Fleten

This figure shows the co-authorship network connecting the top 25 collaborators of Karianne G. Fleten. A scholar is included among the top collaborators of Karianne G. Fleten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karianne G. Fleten. Karianne G. Fleten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Ichiaki, Abdelrahman Yousef, Saikat Chowdhury, et al.. (2023). Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma. Cancer Research. 83(19). 3184–3191. 4 indexed citations
2.
Hyldbakk, Astrid, Karianne G. Fleten, Sofie Snipstad, et al.. (2023). Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models. Nanomedicine Nanotechnology Biology and Medicine. 48. 102656–102656. 11 indexed citations
3.
Nyakas, Marta, Karianne G. Fleten, Mads H. Haugen, et al.. (2022). AXL inhibition improves BRAF-targeted treatment in melanoma. Scientific Reports. 12(1). 5076–5076. 28 indexed citations
4.
Fleten, Karianne G., Astrid Hyldbakk, Berit L. Strand, et al.. (2022). Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug Delivery. Marine Drugs. 20(12). 744–744. 9 indexed citations
5.
Lund‐Andersen, Christin, et al.. (2021). Omics analyses in peritoneal metastasis—utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review. Journal of Gastrointestinal Oncology. 12(S1). S191–S203. 17 indexed citations
6.
Fleten, Karianne G., Ketil André Camilio, Terje Vasskog, et al.. (2021). Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer. Scientific Reports. 11(1). 6731–6731. 7 indexed citations
7.
Andersson, Yvonne, Karianne G. Fleten, Torveig Weum Abrahamsen, et al.. (2021). Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale. Cancers. 13(11). 2819–2819. 6 indexed citations
8.
Fleten, Karianne G., Christin Lund‐Andersen, Torveig Weum Abrahamsen, et al.. (2020). Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models. Translational Oncology. 13(8). 100793–100793. 5 indexed citations
9.
Fußer, Markus, Anders Øverbye, Abhilash Pandya, et al.. (2018). Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft. Journal of Controlled Release. 293. 183–192. 43 indexed citations
10.
Andersson, Yvonne, Ben Davidson, Anne Dørum, et al.. (2017). MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer. Oncotarget. 8(37). 61800–61809. 7 indexed citations
11.
Fleten, Karianne G., et al.. (2016). Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases. Clinical & Experimental Metastasis. 34(1). 51–62. 14 indexed citations
12.
Fleten, Karianne G., Anna Barkovskaya, Vigdis Nygaard, et al.. (2016). Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors. Oncotarget. 7(15). 19997–20015. 25 indexed citations
13.
Fleten, Karianne G., Viví Ann Flørenes, Lina Prasmickaite, et al.. (2016). hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma. Cell Death Discovery. 2(1). 16081–16081. 10 indexed citations
14.
Flatmark, Kjersti, Knut Håkon Hole, Torveig Weum Abrahamsen, et al.. (2016). Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer – Targeting the tumor for radiation sensitivity?. Radiotherapy and Oncology. 119(3). 505–511. 8 indexed citations
15.
Emilsen, Elisabeth, Karianne G. Fleten, Birgit Engesæter, et al.. (2015). Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma. BMC Cancer. 15(1). 462–462. 40 indexed citations
16.
Larsen, Roy H., Sebastian Patzke, Karianne G. Fleten, et al.. (2015). Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma. PLoS ONE. 10(6). e0128816–e0128816. 24 indexed citations
17.
Flatmark, Kjersti, Ingrid Jenny Guldvik, Karianne G. Fleten, et al.. (2013). Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies. International Journal of Cancer. 133(6). 1497–1506. 15 indexed citations
18.
Flatmark, Kjersti, Knut Håkon Hole, Torveig Weum Abrahamsen, et al.. (2013). Effect of oxaliplatin-containing neoadjuvant chemotherapy on tumor volume in locally advanced rectal cancer and sensitivity of surviving tumor cells to radiotherapy.. Journal of Clinical Oncology. 31(15_suppl). 3547–3547. 4 indexed citations
19.
Ree, Anne Hansen, et al.. (2012). Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma. Radiation Oncology. 7(1). 165–165. 32 indexed citations
20.
Størvold, Gro Leite, et al.. (2009). Docosahexaenoic Acid Activates Some SREBP‐2 Targets Independent of Cholesterol and ER Stress in SW620 Colon Cancer Cells. Lipids. 44(8). 673–683. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026